| PERIOD ENDING | 5-Dec-09 | 12-Sep-09 | 20-Jun-09 | 28-Feb-09 | | Total Revenue | 1,962,692 | 2,065,061 | 2,790,243 | 2,289,931 | | Cost of Revenue | 1,372,108 | 1,441,703 | 1,945,374 | 1,582,409 | | | Gross Profit | 590,584 | 623,358 | 844,869 | 707,522 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 631,175 | 631,924 | 846,705 | 756,785 | | Non Recurring | 412,560 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (453,151) | (8,566) | (1,836) | (49,263) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,893) | (7,028) | (1,834) | 2,633 | | Earnings Before Interest And Taxes | (469,044) | (15,594) | (3,670) | (46,630) | | Interest Expense | 45,769 | 48,559 | 54,248 | 37,516 | | Income Before Tax | (514,813) | (64,153) | (57,918) | (84,146) | | Income Tax Expense | (12,375) | (1,994) | 386 | (777) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (502,438) | (62,159) | (58,304) | (83,369) | | | Non-recurring Events | | Discontinued Operations | (57,148) | (18,150) | (6,856) | (27,759) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (559,586) | (80,309) | (65,160) | (111,128) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($559,586) | ($80,309) | ($65,160) | ($111,128) |
|